[go: up one dir, main page]

RU2015146972A - FIRST-AID KIT, FIRST, AMBULANCE AND EMERGENCY MEDICAL CARE FOR INFECTED CYANIDES - Google Patents

FIRST-AID KIT, FIRST, AMBULANCE AND EMERGENCY MEDICAL CARE FOR INFECTED CYANIDES Download PDF

Info

Publication number
RU2015146972A
RU2015146972A RU2015146972A RU2015146972A RU2015146972A RU 2015146972 A RU2015146972 A RU 2015146972A RU 2015146972 A RU2015146972 A RU 2015146972A RU 2015146972 A RU2015146972 A RU 2015146972A RU 2015146972 A RU2015146972 A RU 2015146972A
Authority
RU
Russia
Prior art keywords
aid kit
kit according
antidotes
aid
cyanide
Prior art date
Application number
RU2015146972A
Other languages
Russian (ru)
Other versions
RU2637293C2 (en
Inventor
Валерий Юзефович Ковтун
Салават Хамитович Сарманаев
Антон Юрьевич Беловолов
Вадим Дмитриевич Гладких
Владимир Владимирович Гришин
Юрий Александрович Давидович
Виктор Борисович Назаров
Original Assignee
Федеральное государственное унитарное предприятие Научно-производственный центр "Фармзащита" Федерального медико-биологического агентства
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное унитарное предприятие Научно-производственный центр "Фармзащита" Федерального медико-биологического агентства filed Critical Федеральное государственное унитарное предприятие Научно-производственный центр "Фармзащита" Федерального медико-биологического агентства
Priority to RU2015146972A priority Critical patent/RU2637293C2/en
Publication of RU2015146972A publication Critical patent/RU2015146972A/en
Application granted granted Critical
Publication of RU2637293C2 publication Critical patent/RU2637293C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F17/00—First-aid kits

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (6)

1. Аптечка для оказания первой, скорой и экстренной медицинской помощи при отравлении цианидами, содержащая метгемоглобинообразователи, отличающаяся тем, что состоит из трех отделений с вскрывающимися полостями, в полостях находятся лекарственные препараты, имеющие идентификационные надписи, обозначающие названиями лекарственных препаратов, предназначенные для лечения тяжелых, средних и легких степеней поражения цианидами, в одном отделении находятся метгемоглобинообразователи, в других - антидоты других классов для лечения отравлений цианидами; аптечка снабжена утвержденной инструкцией по медицинскому применению.1. First-aid kit for first aid, emergency and emergency medical care for cyanide poisoning, containing methemoglobin formers, characterized in that it consists of three compartments with opening cavities, in the cavities there are drugs with identification labels denoting the names of drugs intended for the treatment of severe , medium and light degrees of cyanide damage, in one compartment are methemoglobin formers, in others - antidotes of other classes for the treatment of poisoning cyanide; The first-aid kit is equipped with approved instructions for medical use. 2. Аптечка по п. 1, отличающаяся тем, что метгемоглобинообразователи выбирают из группы: 4-диметиламинофенола или нитрита натрия в известных лекарственных формах.2. The first-aid kit according to claim 1, characterized in that the methemoglobin formers are selected from the group of: 4-dimethylaminophenol or sodium nitrite in known dosage forms. 3. Аптечка по п. 1, отличающаяся тем, что в другом отделении находится 1,5% раствор эдетата кобальта в 20% растворе декстрозы.3. The first-aid kit according to claim 1, characterized in that in another compartment there is a 1.5% solution of cobalt edetate in a 20% dextrose solution. 4. Аптечка по п. 1, отличающаяся тем, что все препараты для внутривенного введения содержат стерильные наборы для внутривенного введения.4. The first-aid kit according to claim 1, characterized in that all preparations for intravenous administration contain sterile sets for intravenous administration. 5. Аптечка по п. 1, отличающаяся тем, что в третьем отделении находятся антидоты, выбранные из группы: кобальтовая или натриевая соль альфа-кетоглутаровой кислоты или смешанным кобальт(II)овым солям кетокарбоновых и меркаптокарбоновых кислот.5. The first-aid kit according to claim 1, characterized in that the third compartment contains antidotes selected from the group: cobalt or sodium salt of alpha-ketoglutaric acid or mixed cobalt (II) salts of ketocarboxylic and mercaptocarboxylic acids. 6. Аптечка по п. 6, отличающаяся тем, что антидоты находятся в таблетированной лекарственной форме.6. The first-aid kit according to claim 6, characterized in that the antidotes are in tablet dosage form.
RU2015146972A 2015-11-02 2015-11-02 Medical kit for first, ambulance and emergency medical aid for persons affected by cyanides RU2637293C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015146972A RU2637293C2 (en) 2015-11-02 2015-11-02 Medical kit for first, ambulance and emergency medical aid for persons affected by cyanides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015146972A RU2637293C2 (en) 2015-11-02 2015-11-02 Medical kit for first, ambulance and emergency medical aid for persons affected by cyanides

Publications (2)

Publication Number Publication Date
RU2015146972A true RU2015146972A (en) 2017-05-11
RU2637293C2 RU2637293C2 (en) 2017-12-01

Family

ID=58715505

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015146972A RU2637293C2 (en) 2015-11-02 2015-11-02 Medical kit for first, ambulance and emergency medical aid for persons affected by cyanides

Country Status (1)

Country Link
RU (1) RU2637293C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115444857A (en) * 2022-08-30 2022-12-09 安徽丰原药业股份有限公司 Preparation method of cyanide antidotal agent injection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2216299C1 (en) * 2002-02-26 2003-11-20 Дрожжин Анатолий Петрович Specialized kit for rendering aid to victims of stings
RU64057U1 (en) * 2006-12-11 2007-06-27 Общество с ограниченной ответственностью "ПКЦ СпецТехСбыт" INDIVIDUAL FIRST-AID KIT
US20140120159A1 (en) * 2012-10-30 2014-05-01 Sam Houston University Cyanide antidote compositions and methods of use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115444857A (en) * 2022-08-30 2022-12-09 安徽丰原药业股份有限公司 Preparation method of cyanide antidotal agent injection
CN115444857B (en) * 2022-08-30 2023-08-01 安徽丰原药业股份有限公司 Preparation method of cyanide antidote injection

Also Published As

Publication number Publication date
RU2637293C2 (en) 2017-12-01

Similar Documents

Publication Publication Date Title
ES2580127T3 (en) Chronic Nephropathy Treatment Procedure
FI3494972T3 (en) Combinations of dolutegravir and lamivudine for the treatment of hiv infection
RU2016141570A (en) FGFR INHIBITOR AND IGF1R INHIBITOR COMBINATIONS
JP2012515184A5 (en)
JP2016501066A5 (en)
MX390101B (en) Medical treatment comprising enteral administration of edaravone
RU2012154628A (en) Pharmaceutical composition of ibuprofen for injection
RU2015146972A (en) FIRST-AID KIT, FIRST, AMBULANCE AND EMERGENCY MEDICAL CARE FOR INFECTED CYANIDES
Manouchehri et al. Successful treatment of heart failure due to simultaneous poisoning with aluminum phosphide and zinc phosphide: a case report
CN106822090B (en) Application of 3,4,7-trihydroxyisoflavone or 3-methoxydaidzein in the preparation of drugs for inhibiting platelet aggregation and thrombosis
BR112017015338A2 (en) chlorophyllin composition and method for treatment
RU2015111491A (en) COMBINATION OF THE MACROCYCLIC HCV PROTEASE INHIBITOR, HCV NON-NUCLEOSIDE INHIBITOR AND RITONAVIR
Waack et al. L‐Malate’s Plasma and Excretion Profile in the Treatment of Moderate and Severe Hemorrhagic Shock in Rats
Gautam et al. Dengue fever with fulminant liver failure and fatal pulmonary alveolar hemorrhage: a case report
MX387263B (en) PROLONGED-RELEASE PHARMACEUTICAL COMPOSITION COMPRISING CYSTEAMINE OR SALT THEREOF.
RU2016145411A (en) The combination of brexpiprazole and nalmefene, and its use for the treatment of the syndrome of chemical dependence
RU2018108842A (en) METHOD FOR TREATING A DISEASE WITH THE USE OF A COMPOUND EFFECTING ON GLYCOLYSIS
Ciszek Once–versus twice–daily tacrolimus: are the formulations equivalent?
Krishnaswamy et al. Rhabdomyolysis: an unusual complication following diclofenac and amitraz consumption
Manoochehri et al. A case of successful treatment of heart failure due to simultaneous poisoning with aluminum phosphide and zinc phosphide
Baymishev et al. Metrolek-O medicine use for the correction of dairy cows reproductive function
Stiawan et al. Promising Feature and Challenge of Utilizing Erythropoietin Hormone to Support Emergency Teams’ Activities at High-Altitude Geographical Area
RU2015148650A (en) A method for the treatment of patients with allergic diseases with autologous lymphocytes
Sacks et al. 1158: PLASMAPHERESIS SIGNIFICANTLY REDUCES SERUM AMLODIPINE LEVELS FOLLOWING INTENTIONAL OVERDOSE
Avcı et al. Ataxia caused by a single dose of dexketoprofen trometamol